Literature DB >> 10787451

Determinants of raised C-reactive protein concentration in type 1 diabetes.

E S Kilpatrick1, B G Keevil, C Jagger, R J Spooner, M Small.   

Abstract

As a marker of systemic inflammation, raised C-reactive protein (CRP) concentrations which are still within the normal range have been associated with an increased incidence of coronary heart disease (CHD) in non-diabetic subjects. This study aimed to establish potential determinants of raised CRP concentrations in type 1 diabetic patients. We used a sensitive assay to measure 'low-level' CRP concentrations in 167 type 1 patients (93M, 74F, median age 30 years, range 13-67). Stepwise multivariate analysis was used to relate these CRP levels to known cardiovascular risk factors and demographic data. Only six patients had established CHD (median CRP 3.34 mg/l vs. 0.83 mg/l, p=0.032). In subjects without overt CHD, multivariate analysis showed increases in subject age (p=0.0025), BMI (p=0.001) and HbA(1) (p=0.012) to be associated with a higher CRP concentration, as was female sex (p=0.026) and a history of CHD in a first-degree relative (p=0.018, n=57). The duration of diabetes, current smoking status, presence of microvascular complications, lipid status and presence of hypertension were unrelated. This study suggests that some of the risk factors associated with CHD in type 1 patients are also independently predictive of high CRP concentrations. The reasons for this, and whether intervention would prove useful, require further investigation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10787451     DOI: 10.1093/qjmed/93.4.231

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  6 in total

1.  Obesity and coronary artery calcium in diabetes: the Coronary Artery Calcification in Type 1 Diabetes (CACTI) study.

Authors:  Ticiana C Rodrigues; Adrienne M Veyna; Michelle D Haarhues; Gregory L Kinney; Marian Rewers; Janet K Snell-Bergeon
Journal:  Diabetes Technol Ther       Date:  2011-07-19       Impact factor: 6.118

2.  Arterial stiffness is increased in patients with type 1 diabetes without cardiovascular disease: a potential role of low-grade inflammation.

Authors:  Gemma Llauradó; Victòria Ceperuelo-Mallafré; Carme Vilardell; Rafael Simó; Núria Freixenet; Joan Vendrell; José Miguel González-Clemente
Journal:  Diabetes Care       Date:  2012-02-22       Impact factor: 19.112

3.  Serum adiponectin and hsCRP levels and non-invasive radiological methods in the early diagnosis of cardiovascular system complications in children and adolescents with type 1 diabetes mellitus.

Authors:  Damla Gökşen; Ertürk Levent; Sakine Kar; Samim Ozen; Sükran Darcan
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013-09-10

4.  Elevated Serum Levels of Soluble TNF Receptors and Adhesion Molecules Are Associated with Diabetic Retinopathy in Patients with Type-1 Diabetes.

Authors:  Shruti Sharma; Sharad Purohit; Ashok Sharma; Diane Hopkins; Leigh Steed; Bruce Bode; Stephen W Anderson; Ruth Caldwell; Jin-Xiong She
Journal:  Mediators Inflamm       Date:  2015-08-03       Impact factor: 4.711

5.  Biomarkers of inflammation and endothelial dysfunction as predictors of pulse pressure and incident hypertension in type 1 diabetes: a 20 year life-course study in an inception cohort.

Authors:  Isabel Ferreira; Peter Hovind; Casper G Schalkwijk; Hans-Henrik Parving; Coen D A Stehouwer; Peter Rossing
Journal:  Diabetologia       Date:  2017-11-03       Impact factor: 10.122

Review 6.  Inflammatory and cardiovascular diseases biomarkers in chronic hepatitis C virus infection: A review.

Authors:  Ahmed Babiker; Mohamed Hassan; Safwan Muhammed; Gregory Taylor; Bhawna Poonia; Anoop Shah; Shashwatee Bagchi
Journal:  Clin Cardiol       Date:  2019-11-30       Impact factor: 2.882

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.